14 Atopic Dermatitis Clinical Trials in Salt Lake City, UT (2026)

Q: How do I join a clinical trial in Salt Lake City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you.

Recruiting Atopic Dermatitis Studies in Salt Lake City

NCT05875168Recruiting

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

This study will evaluate the safety, tolerability, and efficacy of DS-3939a in participants with advanced solid tumors....

Salt Lake City, UTPHASE1590 participantsDaiichi Sankyo

View Study Details

NCT06032559Recruiting

Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment

This hybrid implementation-effectiveness trial will evaluate Mindfulness-Oriented Recovery Enhancement (MORE) for patients with opioid use disorder receiving methadone treatment (MT). The investigator...

Salt Lake City, UTPHASE3450 participantsRutgers, The State University of New Jersey

View Study Details

NCT06033599Recruiting

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake...

Salt Lake City, UTPHASE3420 participantsRutgers, The State University of New Jersey

View Study Details

NCT06973564Recruiting

JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

This study is to evaluate the safety and tolerability of JAB-23E73 in adult participants with advanced solid tumors...

Salt Lake City, UTPHASE1294 participantsJacobio Pharmaceuticals Co., Ltd.

View Study Details

NCT06039176Recruiting

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

Durable left ventricular assist devices (dLVAD) have been increasingly utilized since the mid to late 1990s, with an uptick of utility starting in 2010 following expanded indications for therapy to no...

Salt Lake City, UT150 participantsInternational Consortium of Circulatory Assist Clinicians

View Study Details

NCT07436793Recruiting

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

This phase II trial tests compares the effect of progestins, megestrol acetate to micronized progesterone, in treating patients with endometrial cancer and precancers of the uterus (atypical endometri...

Salt Lake City, UTPHASE2140 participantsNew Mexico Cancer Research Alliance

View Study Details

NCT06249048Recruiting

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Phase 1/2, Open-label, Multi-center, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of STX-001 Delivered by Intratumoral Injection in Pati...

Salt Lake City, UTPHASE1108 participantsStrand Therapeutics Inc.

View Study Details

NCT05490472Recruiting

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

This study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors....

Salt Lake City, UTPHASE1102 participantsJacobio Pharmaceuticals Co., Ltd.

View Study Details

NCT07282587Recruiting

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG)....

Salt Lake City, UTPHASE290 participantsJazz Pharmaceuticals

View Study Details

NCT06352359Recruiting

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

This is a Phase I/II open label study of intravenous (IV) infusion of ONC-841 as a single agent or in combination in patients with advanced/metastatic solid tumors. The study will evaluate seven dose ...

Salt Lake City, UTPHASE172 participantsOncoC4, Inc.

View Study Details

NCT05329103Recruiting

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

This is a first-in-human, dose escalation, repeat-dose, multi-center, open-label study evaluating safety, tolerability, PK, and preliminary antitumor activity of PEEL-224 in patients with advanced sol...

Salt Lake City, UTPHASE165 participantsPeel Therapeutics Inc

View Study Details

NCT06096974Recruiting

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

This study will evaluate the safety, tolerability, drug levels, pharmacodynamic effects, and clinical activity of YL 17231 in patients with advanced solid tumors harboring mutations in KRAS, HRAS, or ...

Salt Lake City, UTPHASE160 participantsShanghai YingLi Pharmaceutical Co. Ltd.

View Study Details

NCT06557733Recruiting

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

This open-label phase II trial tests how well TPST-1495 works in reducing the number of polyps in the small bowel and colon in patients with familial adenomatous polyposis (FAP). FAP is an inherited c...

Salt Lake City, UTPHASE238 participantsNational Cancer Institute (NCI)

View Study Details

NCT06108089Recruiting

Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment

Tumor hypoxia is one of the physiological factors for treatment resistance and likely contributes to poor overall survival among patients with head and neck cancer (HNC). Identifying hypoxic features ...

Salt Lake City, UT20 participantsUniversity of Utah

View Study Details

About Atopic Dermatitis Clinical Trials in Salt Lake City

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 14 atopic dermatitis clinical trials recruiting participants in Salt Lake City, UT. These studies are seeking a combined 2,599 participants. Research is being sponsored by Daiichi Sankyo, Rutgers, The State University of New Jersey, Jacobio Pharmaceuticals Co., Ltd. and 9 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Salt Lake City — FAQ

Are there atopic dermatitis clinical trials in Salt Lake City?

Yes, there are 14 atopic dermatitis clinical trials currently recruiting in Salt Lake City, UT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Salt Lake City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you about next steps.

Are clinical trials in Salt Lake City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Salt Lake City studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 14 active trials in Salt Lake City are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated October 12, 2026 from ClinicalTrials.gov